Tech/Media/Telecom Weekly: State AGs and Nexstar Aren’t Talking; Court Ruling Spells Trouble for Price-Fixing Defendants; Payments Network Could Evade Russia Sanctions; Trinidad and Tobago Chases Tech Revenue; Candidates Detail Opposition to Data Centers

The TMT Weekly is a forward-looking tipsheet that covers tech policy across The Capitol Forum’s U.S. policy coverage universe, from Congress to the courts. If you have any feedback, feel free to email editorial@thecapitolforum.com. In this edition: • Media Outlook: The chances of a settlement in California’s case against Nexstar’s $6.2 billion merger with Tegna […]

Capitol Forum Analysis of September MAUDE Data

The information contained in this report is compiled from the FDA’s Manufacturer and User Facility Device Experience (MAUDE) database. The MAUDE database contains reports of deaths, injuries, and...

Oct 21, 2026 Read Now >

EU Hybrid Quota Plan Raises Concerns Among Key Trading Partners, Sources Say

The European Commission has told the EU’s main trading partners that it plans to calculate country- specific quotas for hybrid car exports using 2025 import levels as a baseline, according to...

Oct 20, 2026 Read Now >

Silgan: After Disregarding High Mold and Yeast Results in Manufactured Products, FDA Says Company Should Overhaul Quality System; Expert Says Findings Place Companies at Risk of FDA Withholding Approvals for Product Applications

Silgan Dispensing Systems (SLGN), a contract manufacturer of consumer health care products, didn’t properly investigate or report high mold and yeast counts for drug products made in its...

Oct 20, 2026 Read Now >

Tech/Media/Telecom Weekly: State AGs and Nexstar Aren’t Talking; Court Ruling Spells Trouble for Price-Fixing Defendants; Payments Network Could Evade Russia Sanctions; Trinidad and Tobago Chases Tech Revenue; Candidates Detail Opposition to Data Centers

RELATED ARTICLES | Antitrust Policy

Capitol Forum Analysis of September MAUDE Data

EU Hybrid Quota Plan Raises Concerns Among Key Trading Partners, Sources Say

Silgan: After Disregarding High Mold and Yeast Results in Manufactured Products, FDA Says Company Should Overhaul Quality System; Expert Says Findings Place Companies at Risk of FDA Withholding Approvals for Product Applications

FILTER BY

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.